INS and diabetes mellitus: Innovations in glucose monitoring and the rapid development of hybrid closed-loop insulin delivery systems have improved quality of life for patients living with diabetes (23), and ongoing clinical trials of novel stem-cell derived islet cell therapy have published early and highly promising results (24).